Skip to content

Cohort study of traditional Chinese medicine intervention on the treatment of aplastic anemia and its effect on reducing the recurrence rate

Cohort study of traditional Chinese medicine intervention on the treatment of aplastic anemia and its effect on reducing the recurrence rate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006835
Enrollment
Unknown
Registered
2015-07-29
Start date
2015-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aplastic anemia

Interventions

Integrated treatment group:Invigorating kidney and promoting blood dicoction of Chinese medcine
Control group:Yiqiyangxue Dicoction of Chinese medicine

Sponsors

Xiyuan Hospital affiliated to China Academy of Traditional Chinese Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. The accordition with the diagnostic criteria of aplastic anemia; 2. Age >14 years old and <80 years old,with the normal function of liver and kidney; 3. The course of disease was less than half a year, or the duration of the disease was more than half a year but with no formal treatment; 4. He or she did not participate in clinical research at the same time.

Exclusion criteria

Exclusion criteria: 1. Other diseases caused by the reduction of whole blood cells, such as paroxysmal nocturnal hemoglobin, bone marrow hyperplasia syndrome, acute hematopoietic function arrest, bone marrow fibrosis; 2. Patients with the congenital aplastic anemia; 3. Patients with severe heart disease, brain, liver, kidney disease and mental disease; 4. The pregnant, lactating women.

Design outcomes

Primary

MeasureTime frame
Routine blood test;CD3+CD19-T cell;Th1/Th2;CD3+CD4+CD8+ T cell;CD3+CD4-CD8+T cell;CD3+DR+T cell;CD3+CD25+T cell;the gene of T-bet;the gene of GATA-3;

Countries

China

Contacts

Public ContactLiu Feng
liufengdoctor@126.com+86 13701249039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026